---
schema_version: "secwatch.filing_event.v1"
accession: "0001356576-26-000028"
form_type: "8-K"
ticker: "SUPN"
cik: "0001356576"
company_name: "SUPERNUS PHARMACEUTICALS, INC."
filed_at: "2026-06-18T20:55:31+00:00"
generated_at: "2026-06-18T20:57:14.935854+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Supernus shareholders approve all proposals, including equity plan share increase

## Summary
- Elected Class I directors Frederick M. Hudson (45.1M for) and Charles W. Newhall, III (41.7M for).
- Say-on-pay approved with 45.6M votes for, 1.7M against, 7.7K abstain.
- Ratified KPMG as auditor for FY2026 (49.9M for, 417K against).
- Amendment to 2021 Equity Incentive Plan to increase shares available passed (41.9M for, 5.3M against).

## SEC filing metadata
- accession: 0001356576-26-000028
- form_type: 8-K
- ticker: SUPN
- cik: 0001356576
- company_name: SUPERNUS PHARMACEUTICALS, INC.
- filed_at: 2026-06-18T20:55:31+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1356576/000135657626000028/0001356576-26-000028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1356576/000135657626000028/supn-20260618.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001356576-26-000028
- JSON: https://secwatch.observer/filing/0001356576-26-000028.json
- Plain text: https://secwatch.observer/filing/0001356576-26-000028.txt

## Key facts
- Shareholder Votes
  SUPERNUS PHARMACEUTICALS, INC. shareholders approved To approve, on a non-binding basis, the compensation paid to our named executive officers. at the 2026-06-18 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-18
  source text: Proposal 2: To approve, on a non-binding basis, the compensation paid to our named executive officers. Votes For Votes Against Abstain Broker Non-Votes 45,552,633 1,675,355 7,714 3,073,181
  evidence_url: https://www.sec.gov/Archives/edgar/data/1356576/000135657626000028/0001356576-26-000028-index.htm
- Shareholder Votes
  SUPERNUS PHARMACEUTICALS, INC. shareholders approved Ratification of the appointment of KPMG LLP as the Company's independent public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-18 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-18
  source text: Proposal 3: Ratification of the appointment of KPMG LLP as the Company's independent public accounting firm for the fiscal year ending December 31, 2026. Votes For Votes Against Abstain Broker Non-Votes 49,882,228 417,336 9,319 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1356576/000135657626000028/0001356576-26-000028-index.htm
- Shareholder Votes
  SUPERNUS PHARMACEUTICALS, INC. shareholders approved To act upon a proposal to amend the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan to increase the number of shares available under the Plan. at the 2026-06-18 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2026-06-18
  source text: Proposal 4: To act upon a proposal to amend the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan (the "Plan") to increase the number of shares available under the Plan. Votes For Votes Against Abstain Broker Non-Votes 41,925,692 5,302,088 7,922 3,073,181
  evidence_url: https://www.sec.gov/Archives/edgar/data/1356576/000135657626000028/0001356576-26-000028-index.htm
- Shareholder Votes
  SUPERNUS PHARMACEUTICALS, INC. shareholders approved Election of Class I Directors at the 2026-06-18 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-18
  source text: Proposal 1: Election of Class I Directors, each to serve until the Annual Meeting of the Company in 2029. Name Votes For Votes Withheld Broker Non-Votes Frederick M. Hudson 45,058,634 2,177,068 3,073,181 Charles W. Newhall, III 41,743,154 5,492,548 3,073,181
  evidence_url: https://www.sec.gov/Archives/edgar/data/1356576/000135657626000028/0001356576-26-000028-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.